Nrxs stock price.
The decrease of $4.4 million was primarily, related to a decrease of $3.9 million in legal, professional and accounting fees, $0.6 million in insurance expenses, $0.5 million in stock-based ...
7,529.351.01%) Dow JonesNRXS's current price target is $0.00. Learn why top analysts are making this stock forecast for NeurAxis at MarketBeat.NRXP | Complete NRX Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Nov 27, 2023 · See the latest Neuraxis Inc stock price (NRXS:XASE), related news, valuation, dividends and more to help you make your investing decisions. When it comes to purchasing a new vehicle, finding the perfect car that meets all your requirements can be a daunting task. If you have your heart set on a Genesis GV70, you’ll want to ensure that you find the best one available in stock.
The cheapest stocks—known as penny stocks —also tend to be the riskiest. A stock that has dropped from $40 to $4 may well end up at $0, while a stock that goes from $10 to $20 might double ...
Average. $3.08. Current Price. $0.31. Options. Overview. Research & Ratings. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume ...
Find the latest NRx Pharmaceuticals, Inc. (NRXP) stock quote, history, news and other vital information to help you with your stock trading and investing. Aug-09-23 10:00AM. NeurAxis Announces Pricing of Initial Public Offering. (GlobeNewswire) NeurAxis, Inc. develops neuromodulation therapies to address chronic …Neuraxis Inc. stock price (NRXS) NYSE MKT: NRXS. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Neuraxis Inc. stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting.The consensus price target of analysts on Wall Street is $75.38, which implies an increase of 63.94% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $53.00 and $120.00 respectively. As a result, PLL is trading at a discount of -341.5% off the target high and -95.0% off the low.It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Price/Cash Flow: Latest closing price divided by the last 12 months revenue/cash flow per share.
Average. $3.08. Current Price. $0.31. Options. Overview. Research & Ratings. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume ...
Full Company Report for NRXS. View Neuraxis, Inc NRXS investment & stock information. Get the latest Neuraxis, Inc NRXS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
The 2022 Senior Secured Convertible Promissory Notes are convertible into shares of common stock at the lower of (a) $9.44 per share, or (b) a discount of 30% to the price per share in any subsequent offering, subject to adjustment in the event of common stock distribution, stock splits, fundamental transactions, dilutive issuances or similar ...Up to date market data and stock market news is available online. View US market headlines and market charts. Get the latest economy news, markets in our Market Overview.View the latest AT&T Inc. (T) stock price, news, historical charts, analyst ratings and financial information from WSJ.Source: Kantar Media. View the latest Neuraxis Inc. (NRXS) stock price, news, historical charts, analyst ratings and financial information from WSJ.CARMEL, Ind., Nov. 15, 2023 (GLOBE NEWSWIRE) -- NeurAxis, Inc. ('NeurAxis,' or the 'Company') (NYSE American: NRXS), a medical technology company commercializing ...
In addition, the Company has granted the underwriters a 45-day option to purchase up to 164,800 additional shares of common stock at the initial public offering price, less the underwriting discount.7,529.351.01%) Dow JonesFind the latest NRx Pharmaceuticals, Inc. (NRXP) stock quote, history, news and other vital information to help you with your stock trading and investing. Find the latest NeurAxis, Inc. (NRXS) stock quote, history, news and other vital information to help you with your stock trading and investing.Neuraxis Inc. advanced stock charts by MarketWatch. View NRXS historial stock data and compare to other stocks and exchanges.How To Navigate IBS and Tempting Food Over the Holidays? With the holiday season now in full swing, tempting foods that could cause gastrointestinal distress…Goldman Small Cap Research, a stock market research firm specializing in the small cap and microcap sectors, announced today that it has published a new research report on NeurAxis, Inc.. NeurAxis ...
NRXS stock data, price, and news. View NRXS insider trading, corporate lobbying, Congressional trading, social media sentiment, and more.
According to one analyst, the rating for NRXP stock is "Strong Buy" and the 12-month stock price forecast is $2.0. Price Target. $2.0 (466.57% upside)Nov 21, 2023 · Stock analysis for Neuraxis Inc (NRXS:NYSEAmerican) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Neuraxis Inc Stock Earnings. The value each NRXS share was expected to gain vs. the value that each NRXS share actually gained. Neuraxis Inc ( NRXS) reported Q2 2023 earnings per share (EPS) of -$1.24, missing estimates of -$0.22 by 461.73%. In the same quarter last year, Neuraxis Inc 's earnings per share (EPS) was -$0.87.Nov 27, 2023 · Summary of all time highs, changes and price drops for NeurAxis; Historical stock prices; Current Share Price: US$3.00: 52 Week High: US$6.93: 52 Week Low Every 27 seconds someone in the U.S. attempts suicide 11-20% of people with bipolar disorder will die by suicide 0 Approved drugs exist today for suicidal bipolar depression NRx-101 is the first investigational drug in FDA trials for suicidal bipolar depression, awarded fast track designation, breakthrough therapy designation, and a special protocol agreement …Nov 29, 2023 · A high-level overview of NRx Pharmaceuticals, Inc. (NRXP) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. 356.63%. Free cash flow. Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. 8.05B. 806.56%. Get the latest Meta Platforms Inc (FB) real ...
NeurAxis (NRXS) Stock Price, News & Analysis $2.41 +0.07 (+2.99%) (As of 11/21/2023 ET) Compare Today's Range $2.34 $2.44 50-Day Range $1.90 $4.66 52 …
Neuraxis Inc Stock Earnings. The value each NRXS share was expected to gain vs. the value that each NRXS share actually gained. Neuraxis Inc ( NRXS) reported Q2 2023 earnings per share (EPS) of -$1.24, missing estimates of -$0.22 by 461.73%. In the same quarter last year, Neuraxis Inc 's earnings per share (EPS) was -$0.87.
Shares of NRx Pharmaceuticals ( NRXP 2.55%) surged on Monday after the healthcare company released promising clinical trial data for its investigational COVID-19 treatment, aviptadil. By the close ...Jan 12, 2023 · Tharakorn. A Quick Take On Neuraxis. Neuraxis (NYSE:NRXS) has filed to raise $33.3 million in an IPO of its common stock, according to an S-1 registration statement.The firm is commercializing ... Sioux Falls, SD 57103 Email: [email protected] Phone: (844) 978-6257. Defense World members receive the latest stock market news and a concise summary of new analysts' recommendations in a FREE ...Jul 22, 2021 · What happened. Shares of NRx Pharmaceuticals ( NRXP -5.47%) were trading 70.1% higher as of 11:58 a.m. EDT on Thursday after the company announced that it had validated a formulation for COVID-19 ... 52 Week Range 2.38 - 48.80. in 2020 the stock was $77. My price NRx Pharmaceuticals, Inc. (NRXP) has two Phase III assets for which it has Fast Track and Breakthrough Therapy designation, respectively: intravenous ZYESAMI® for Critical COVID-19 and NRX-101 for bipolar depression with suicidality. 52 Week Range 2.38 - 48.80. in 2020 the stock ...In addition, the Company has granted the underwriters a 45-day option to purchase up to 164,800 additional shares of common stock at the initial public offering price, less the underwriting discount.May 16, 2023 · NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced its financial results for the first quarter of 2023 and ... Discover historical prices for NRXP stock on Yahoo Finance. View daily, weekly or monthly format back to when NRx Pharmaceuticals, Inc. stock was issued.Get real-time NASDAQ Last Sale Intraday Trade History Report, commonly referred to as "Time & Sales," shows the last-five real-time time and sales data for all of your favorite U.S. stocks (listed ...Concurrent with the listing, NeurAxis announced the pricing of its underwriter's initial public offering of 1,098,667 shares of common stock at a price of $6 per share.
(RTTNews) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 07.50 A.M. ET). In the Green Mobilicom Limited (MOB) is up over 46% at $2.08.Neuraxis Inc Neuraxis Inc NRXS Morningstar Rating Unlock Stock XASE Rating as of Nov 27, 2023 Summary Chart News Price vs Fair Value Sustainability …Get alerts on latest IPO news stories along with upcoming, open and listing IPO dates & offer price details. ... We expect to see about 14 new companies on the stock market soon. This busy time in the market is probably because more people are buying things, businesses are using their full potential, and generally, people are feeling good …According to the issued ratings of 2 analysts in the last year, the consensus rating for NRx Pharmaceuticals stock is Buy based on the current 2 buy ratings for NRXP. The average twelve-month price prediction for NRx Pharmaceuticals is $2.00 with a high price target of $2.00 and a low price target of $2.00. Learn more on NRXP's analyst rating ...Instagram:https://instagram. top fha mortgage lendersbest free crypto exchangevoo stock holdingselon musk stock portfolio Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan... aprilarnt news Neuraxis Inc. advanced stock charts by MarketWatch. View NRXS historial stock data and compare to other stocks and exchanges.Detailed statistics for NeurAxis, Inc. (NRXS) stock, including valuation metrics, financial numbers, share information and more. Detailed statistics for NeurAxis, Inc. (NRXS) stock, including valuation metrics, financial numbers, share information and more. ... NRXS · IEX Real-Time Price · USD. Add to Watchlist 3.16-0.10 (-3.07%) Nov 30, 2023 ... cat stocks The consensus price target of analysts on Wall Street is $3.08, which implies an increase of 87.99% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $2.00 and $5.25 respectively. As a result, NRXP is trading at a discount of -1318.92% off the target high and -440.54% off the low.Stock price quote for Neuraxis Inc, symbol NRXS, Nasdaq Stock Exchange. Quote data is updated continously during trading hours.